<DOC>
	<DOCNO>NCT00850811</DOCNO>
	<brief_summary>This Phase 1 study design determine photoirritation potential PEP005 Gel , 0.01 % application follow light exposure .</brief_summary>
	<brief_title>A Study Evaluate Photoirritation Potential PEP005 ( Ingenol Mebutate ) Gel , 0.01 % Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>healthy male female ; case females childbearing potential , must use effective contraception must provide negative pregnancy test ; must read , understand provide sign informed consent . willing refrain use topical/systemic analgesic within 72 hour prior study ; use systemic/locallyacting medication study within 2 week prior begin study ; use systemic/locallyacting antiinflammatories study within 72 hour prior begin study ; participate clinical test investigational drug within 28 day clinical patch application within 14 day prior enrollment currently participate clinical testing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Peplin</keyword>
	<keyword>PEP005</keyword>
</DOC>